Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine

Vaccination against COVID-19 in patients with end-stage renal disease (ESRD) on replacement therapy and kidney transplant recipients (KTRs) is particularly important due to the high mortality rate. Here, we tested the local and systemic immunity to the novel Pfizer BioNTech (BNT162b2) messenger RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Piotrowska, Magdalena, Zieliński, Maciej, Tylicki, Leszek, Biedunkiewicz, Bogdan, Kubanek, Alicja, Ślizień, Zuzanna, Polewska, Karolina, Tylicki, Piotr, Muchlado, Marta, Sakowska, Justyna, Renke, Marcin, Sudoł, Adam, Dąbrowska, Małgorzata, Lichodziejewska-Niemierko, Monika, Smiatacz, Tomasz, Dębska-Ślizień, Alicja, Trzonkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354587/
https://www.ncbi.nlm.nih.gov/pubmed/35935974
http://dx.doi.org/10.3389/fimmu.2022.832924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354587/
https://www.ncbi.nlm.nih.gov/pubmed/35935974
http://dx.doi.org/10.3389/fimmu.2022.832924

Ejemplares similares